Semba; Taro

Patent Applications and Registrations

Patent applications and USPTO patent grants for Semba; Taro.The latest application filed is for "pharmaceutical composition for treating tumor".

Company Profile

3.9.19

Semba; Taro - Tsukuba-shi JP
Semba; Taro - Tsukuba JP
Semba; Taro - Ibaraki JP

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Pharmaceutical Composition for Treating Tumor App 20220117933 - Semba; Taro ; et al.	2022-04-21
Pharmaceutical composition for treating tumor Grant 11,083,705 - Semba , et al. August 10, 2	2021-08-10
Pharmaceutical Composition For Treating Tumor App 20210177802 - Semba; Taro ; et al.	2021-06-17
Pharmaceutical Composition For Treating Tumor App 20210023047 - Semba; Taro ; et al.	2021-01-28
Method for Predicting Effectiveness of Angiogenesis Inhibitor App 20200199689 - Semba; Taro ; et al.	2020-06-25
Method For Predicting Effectiveness Of Angiogenesis Inhibitor App 20170191137 - Semba; Taro ; et al.	2017-07-06
Use of sulfonamide-including compounds in combination with angiogenesis inhibitors Grant 8,772,269 - Owa , et al. July 8, 2	2014-07-08
Method For Predicting Effectiveness Of Angiogenesis Inhibitor App 20140148483 - Semba; Taro ; et al.	2014-05-29
Novel Marker For Sensitivity Against Sulfonamide Compound App 20100291592 - Semba; Taro	2010-11-18
Integrin expression inhibitor Grant 7,834,049 - Wakabayashi , et al. November 16, 2	2010-11-16
Integrin Expression Inhibitor App 20100267754 - WAKABAYASHI; Toshiaki ; et al.	2010-10-21
Method For Prediction Of The Efficacy Of Vascularization Inhibitor App 20100105031 - Matsui; Junji ; et al.	2010-04-29
Antitumor Agent Comprising Sulfonamide-containing Heterocyclic Compound Combined With An Angiogenesis Inhibitor App 20090269352 - WAKABAYASHI; Toshiaki ; et al.	2009-10-29
Novel Concomitant Use of Sulfonamide Compound with Anti-Cancer Agent App 20090047365 - Owa; Takashi ; et al.	2009-02-19
Novel Combinational Use of Sulfonamide Compound App 20090047278 - Owa; Takashi ; et al.	2009-02-19
Novel Use of Sulfonamide Compound in Combination with Angiogenesis Inhibitor App 20080286282 - Semba; Taro ; et al.	2008-11-20
Use of sulfonamide-including compounds in combination with angiogenesis inhibitors App 20060135486 - Owa; Takashi ; et al.	2006-06-22
Integrin expression inhibitor App 20050176712 - Wakabayashi, Toshiaki ; et al.	2005-08-11
Antitumor agent comprising combination of sulfonamide-containing heterocyclic compound with an angiogenesis inhibitor App 20050119303 - Wakabayashi, Toshiaki ; et al.	2005-06-02
Sulfonamide-containing heterocyclic compounds Grant 6,787,534 - Haneda , et al. September 7, 2	2004-09-07
Integrin expression inhibitors App 20040018192 - Wakabayashi, Toshiaki ; et al.	2004-01-29
Sulfonamide-containing indole compounds Grant 6,673,787 - Haneda , et al. January 6, 2	2004-01-06
Physiologically active substances Grant 6,645,996 - Wakabayashi , et al. November 11, 2	2003-11-11
Sulfonamide-containing indole compounds Grant 6,638,964 - Haneda , et al. October 28, 2	2003-10-28
Sulfonamide-containing heterocyclic compounds App 20030144507 - Haneda, Toru ; et al.	2003-07-31
Sulfonamide-containing indole compounds Grant 6,469,043 - Haneda , et al. October 22, 2	2002-10-22
Sulfonamide-containing indole compounds App 20020128480 - Haneda, Toru ; et al.	2002-09-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.